FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online March 19, 2004 as doi:10.1096/fj.03-0612fje.
Published as doi: 10.1096/fj.03-0612fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/7/848
03-0612fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPIJKER, S.
Right arrow Articles by SMIT, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPIJKER, S.
Right arrow Articles by SMIT, A. B.
(The FASEB Journal. 2004;18:848-850.)
© 2004 FASEB

Morphine exposure and abstinence define specific stages of gene expression in the rat nucleus accumbens 1

SABINE SPIJKER*,2,3, SIARD W. J. HOUTZAGER*,2, MATHISCA C. M. DE GUNST{dagger}, WIM P. H. DE BOER{ddagger}, ANTON N. M. SCHOFFELMEER§ and AUGUST B. SMIT*

* Department of Molecular and Cellular Neurobiology, Graduate School Neurosciences Amsterdam, Research Institute Neurosciences,
{dagger} Department of Mathematics, Faculty of Sciences, Vrije Universiteit, Amsterdam, The Netherlands; and Departments of
{ddagger} Medical Oncology, and
§ Medical Pharmacology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands

3Correspondence: Department of Molecular and Cellular Neurobiology, Vrije Universiteit, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands. E-mail: sspijker{at}bio.vu.nl

SPECIFIC AIMS

The aim was to gain insight in the temporal profile of gene expression in the nucleus accumbens (NAc), related to development and endurance of morphine-induced neuroplasticity. We used a morphine administration paradigm, which yields a morphologically, biochemically, and behaviorally defined neuro-adapted state. This allowed the study of expression profiles of major gene families with roles in intra- and intercellular signaling and transcriptional regulation that are deemed important for development of drug-induced neuroplasticity. Temporal expression profiles of 159 genes were measured in the nucleus accumbens during a 2 wk exposure to morphine (days 1, 2, 4, 8, and 14) and during a 3 wk morphine-free abstinence period (days 1, 2, 4, 8, 12, and 18) (Fig. 1 ). Mapping the temporal expression profile of these genes and their dynamics in the exposure and abstinence phase is a first step to gain insight in their possible role in development of drug-induced neuro-adaptation.



View larger version (46K):
[in this window]
[in a new window]
 
Figure 1. Schedule of morphine administration and tissue collection. A morphine administration paradigm known to induce alteration in neuronal morphology, biochemistry, and behavior was used to examine morphine-responsive gene expression during morphine exposure (14 daily injections for 2 wk) and abstinence from the drug (3 wk) (morphine treatment, gray; saline controls, white). Time points used for tissue collection and gene expression analysis are indicated.

PRINCIPAL FINDINGS

1. Real-time quantitative PCR has the sensitivity and accuracy for neuronal gene expression profiling
We used real-time quantitative PCR to monitor gene expression in order to resolve small changes in expression for genes in various abundance classes. We established its overall sensitivity and resolution by assessing several critical parameters, such as quality of RNA isolation and cDNA synthesis, reproducibility of measurements and biological variation. We show with a measured error mathematical model that the methodological error allows detection of 15–20% difference in gene expression levels. When biological error (biological variation, dissection) is included in this paradigm (Fig. 1) , detection of >35% difference in gene expression levels is feasible.

2. Morphine induces phase-specific temporal gene expression profiles
Daily injections of morphine (Fig. 1) typically induced strong highly dynamic changes in gene expression, thereby characterizing the morphine exposure phase with many different profiles of fluctuating gene expression. These dynamic expression profiles may indicate a homeostatic response to morphine stimulation in order to reach a semi-stable state. In contrast to the exposure phase, expression profiles in the abstinence phase are highly dynamic but coherent (Figs. 2 , 3 ). Abrupt withdrawal of morphine treatment during the first days of the abstinence phase gave rise to a completely new type of response. Typically, compared with the end of the exposure phase, the first two days of drug-abstinence were marked by few down-regulated genes, and some immediate early gene expression (Fig. 2A, D ). After these first two drug-free days most genes showed a down-regulation of expression during the remainder of this period with a major down-regulation at 1 wk of abstinence (Fig. 2) . A few genes showed a marked up-regulation after 2–3 wk of abstinence. Therefore, 1) exposure to morphine and subsequent abstinence from the drug are typified by phase-specific gene expression; and 2) natural withdrawal from morphine is a potent new stimulus in terms of enduring gene expression in the abstinence phase.



View larger version (59K):
[in this window]
[in a new window]
 
Figure 2. Gene expression profiles of various functional groups of genes in the morphine exposure and abstinence phases. Color-coded gene expression: A)red, induction; green, repression; B–E) profiles of individual genes, or averaged gene expression (containing genes indicated by colored vertical bars matching the profile) from several functional groups during exposure and abstinence. Days of treatment and color intensity code for amount of regulation are indicated. Note that receptors directly involved in the processing of the morphine signal, i.e., µ-opioid receptor µ-(OR) and the dopamine receptors (D1, D2L, D2S, D3), are among the early-activated genes (B). C) Ligand-gated ion channels (glutamate and GABAA) show a major repression between 4–12 days of abstinence. D) Transcription factors can be divided into two groups, of which one group is up-regulated at the end of the abstinence-phase and contains the Menin (MENI gene) synapse-stabilizing protein. Gray lines indicate biological significant regulation. E) Subgroups of growth-related molecules contain strongly coregulated genes during exposure and abstinence. Gray lines indicate biological significant regulation. F) Profiles of up-regulated (red) and down-regulated genes (green) during morphine exposure and abstinence is given as the percentage of the total. Days of treatment are indicated. Note substantial repression of gene expression after withdrawal of morphine.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 3. Dynamic regulation of functional groups during exposure and abstinence: overview of dynamic regulation of functional groups of genes during exposure (gray) and abstinence (white). Dynamic regulation is indicated as difference in morphine-induced expression vs. saline control of two consecutive time points (days of treatment: red, induced change; green, repressed change; increase in color brightness indicates increase of change. Responses during the exposure phase are dynamic and differential; responses during the abstinence phase are dynamic and coherent. Note that 1) the majority of dynamic expression is in the abstinence phase; 2) in contrast to the exposure phase, most functional groups are dynamically regulated during abstinence; 3) after a repression between 2 and 8 days, virtually all groups respond between 8–12 days with an increase in gene expression; and 4) at this time point pre/post-synaptic proteins, neurotransmitter (NT) enzymes/transporters, and growth factors are the most dynamically regulated.

3. Phase-specific expression profiles of molecules involved in neurotransmission and neuronal plasticity
Early response genes at morphine exposure are several transcription factors (e.g., krox-20), and immediate early genes (e.g., Arc, c-fos) (Fig. 2D ). During this phase dynamic expression is most prominently and coherently observed for G-protein coupled receptors, e.g., dopamine receptors, and several neuropeptides, as previously reported (Fig. 2B and Fig. 3 ). At the introduction of morphine abstinence early response genes are transcription factors, (e.g., fra-2) and immediate early genes (e.g., Arc, c-fos) (Fig. 2D ). Coherent peak activation of transcription factors, together with a resistance to repression at 1 wk abstinence, suggest that the intermittent morphine regimen followed by drug-abstinence involves a new gene expression program. Part of this program could be neuronal plasticity as reflected by dynamic regulation of trophic factors (receptors) and related molecules during abstinence (Fig. 2E , Fig. 3 ). This complies with the idea that the abstinence period is crucial to development of drug-induced behaviors such as sensitization, drug-seeking, and craving, and to observed concomitant changes in neurotransmitter release and neuronal wiring.

Characteristic of the abstinence phase is the down-regulation at 1 wk abstinence and thereafter found for glutamatergic and GABAergic receptor subunits (Fig. 2C ). This suggests long-term changes in receptor stoichiometries arguing for altered synaptic signaling, probably occurring at 95% of GABAergic medium spiny interneurons of the NAc. A shift in relative expression of NMDA receptor subunits that, as previously suggested may change receptor stoichiometry was found. Long-term down-regulation of all AMPA receptor subunits (Fig. 2C ) may be related to altered dendritic morphology observed long after morphine exposure. Tight coregulation in expression of the channel subunits and their postsynaptic interaction partners, such as the postsynaptic density proteins PSD-95 and Homer-1a, indicates that these receptor-protein complexes may be coordinately regulated to yield adapted post-synaptic structures important for long-term morphine-induced neuronal plasticity (Figs. 2 , 3) .

During abstinence, the groups mostly resistant to repression were transcription factors and several growth-related molecules implicated in growth cone motility and synaptic plasticity. Only a few genes showed up-regulation after 2–3 wk of abstinence, which were mainly transcription factors. In particular molecules such as MEN1, junD, krox-24, Arc, and NAC-1, may play a role in neuronal plasticity (Fig. 2D ). Induction of the transcriptional regulator menin (MEN1 gene), known to repress neuronal outgrowth and to allow generation of central synapses, may play a role at the end of the abstinence phase. The plasticity gene Arc is a marker for recent synaptic activity, and is involved in long-term memory consolidation and impaired maintenance of LTP. A hypothesis worth testing would be that synaptic plasticity may precipitate in stably changed synaptic connections by (long-term) up-regulation of synapse-stabilizing molecules such as Arc and menin. Several trophic factors (receptors) and growth-related molecules show tight coregulation during both exposure and abstinence (Fig. 2E ) (e.g., several ligands and receptor-ligand pairs).

In summary, various functional groups of genes specifically become actively regulated during abstinence, in particular indicating genes involved in aspects of neuronal plasticity (Fig. 3) .

CONCLUSIONS AND SIGNIFICANCE

We have demonstrated that profound gene expression changes occur not only during exposure but also long after cessation of drug-administration (Fig. 2) . The phase-specific expression profiles highlight distinct activities of functional groups of genes (Figs. 2 , 3) . Gene expression changes not only involve elements of synaptic transmission (receptors and interaction partners), but also include proteins implicated in neuronal plasticity (e.g., in outgrowth and synapse formation). The wave of gene expression induced by natural withdrawal and subsequent abstinence might therefore be part of a novel gene program that is essential to previously reported drug-induced morphological reorganization of neuronal networks. In general, persistent changes in gene expression during abstinence may form the molecular basis of drug-induced long-term plasticity. Our findings underscore the notion that discontinuation of drug taking is an important trigger in development of long-term behavioral consequences of repeated drug exposure and is related to behavioral phenomena such as sensitization and addiction.

FOOTNOTES

1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.03-0612fje;

2 These authors contributed equally to this work.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Postmus, A. B. Canelas, J. Bouwman, B. M. Bakker, W. van Gulik, M. J. T. de Mattos, S. Brul, and G. J. Smits
Quantitative Analysis of the High Temperature-induced Glycolytic Flux Increase in Saccharomyces cerevisiae Reveals Dominant Metabolic Regulation
J. Biol. Chem., August 29, 2008; 283(35): 23524 - 23532.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
P. Hawle, D. Horst, J. P. Bebelman, X. X. Yang, M. Siderius, and S. M. van der Vies
Cdc37p Is Required for Stress-Induced High-Osmolarity Glycerol and Protein Kinase C Mitogen-Activated Protein Kinase Pathway Functionality by Interaction with Hog1p and Slt2p (Mpk1p)
Eukaryot. Cell, March 1, 2007; 6(3): 521 - 532.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/7/848
03-0612fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPIJKER, S.
Right arrow Articles by SMIT, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SPIJKER, S.
Right arrow Articles by SMIT, A. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS